Glioblastoma Treatment Drugs Market to Register Strong Growth by 2036 with Increasing Investment in Innovative Neuro-Oncology Therapies
The Glioblastoma Treatment Drugs Market is projected to witness steady growth as the global oncology industry intensifies efforts to improve treatment outcomes for one of the most aggressive forms of brain cancer. According to Future Market Insights (FMI), the market is expected to grow from USD 893.0 million in 2026 to USD 1,554.5 million by 2036, registering a 5.7% CAGR during the forecast...
0 Commentarios 0 Acciones 9 Views 0 Vista previa